1. Falcucci, Lara, Dooley, Christopher M, Adamoski, Douglas, Cirzi, Cansu, Stainier, Didier Y R. 2025. Transcriptional adaptation upregulates utrophin in Duchenne muscular dystrophy. In Nature, 639, 493-502. doi:10.1038/s41586-024-08539-x. https://pubmed.ncbi.nlm.nih.gov/39939773/
2. Zhou, Sitong, Ouyang, Wen, Zhang, Xi, Xiang, Shijian, Li, Jiehua. 2021. UTRN inhibits melanoma growth by suppressing p38 and JNK/c-Jun signaling pathways. In Cancer cell international, 21, 88. doi:10.1186/s12935-021-01768-4. https://pubmed.ncbi.nlm.nih.gov/33632212/
3. Cho, Chul-Hyun, Choi, Ji-Hye, Kang, Seung-Gul, Woo, Hyun Goo, Lee, Heon-Jeong. 2017. A Genome-Wide Association Study Identifies UTRN Gene Polymorphism for Restless Legs Syndrome in a Korean Population. In Psychiatry investigation, 14, 830-838. doi:10.4306/pi.2017.14.6.830. https://pubmed.ncbi.nlm.nih.gov/29209388/
4. Kepreotis, Sacha V, Oh, Jae Gyun, Park, Mina, Hajjar, Roger J, Jeong, Dongtak. 2024. Inhibition of miR-25 ameliorates cardiac and skeletal muscle dysfunction in aged mdx/utrn haploinsufficient (+/-) mice. In Molecular therapy. Nucleic acids, 35, 102174. doi:10.1016/j.omtn.2024.102174. https://pubmed.ncbi.nlm.nih.gov/38584818/
5. Gleneadie, Hannah J, Fernandez-Ruiz, Beatriz, Sardini, Alessandro, Merkenschlager, Matthias, Fisher, Amanda G. 2023. Endogenous bioluminescent reporters reveal a sustained increase in utrophin gene expression upon EZH2 and ERK1/2 inhibition. In Communications biology, 6, 318. doi:10.1038/s42003-023-04666-9. https://pubmed.ncbi.nlm.nih.gov/36966198/